Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma.
Maeda T, Kanzaki H, Chiba T, Ao J, Kanayama K, Maruta S, Kusakabe Y, Saito T, Kobayashi K, Kiyono S, Nakamura M, Ogasawara S, Suzuki E, Ooka Y, Nakamoto S, Nakagawa R, Muroyama R, Kanda T, Maruyama H, Kato N.
Maeda T, et al. Among authors: chiba t.
BMC Cancer. 2019 Nov 12;19(1):1088. doi: 10.1186/s12885-019-6322-9.
BMC Cancer. 2019.
PMID: 31718608
Free PMC article.